Clinical Trial Update: Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether acetylcholinesterase inhibitors affect gait in patients with Parkinson disease; no results are reported and the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Kyung Hee University Hospital | Conditions: Parkinson Disease | Phase 4 | Status: UNKNOWN